We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Improving Heart Failure Outcomes in India: Evidence from the TIME-HF Nurse-Coordinated, Digital-Supported Care Model Trial

MedXY Editorial Team•Sep 1, 2026•Cardiology
heart failuredigital healthnurse-coordinated carerandomized controlled trial


Highlight

  • The TIME-HF cluster RCT demonstrated that a nurse-coordinated, digital-supported collaborative care model significantly increased days alive and out of hospital among patients with heart failure with reduced ejection fraction (HFrEF) in India.
  • The intervention led to a 22% reduction in all-cause mortality compared with usual care over a 2-year follow-up period.
  • The study underscores the feasibility and effectiveness of integrating mobile health technology with nurse-led care for chronic heart failure management in resource-constrained, predominantly rural Indian contexts.
  • This model may serve as a scalable strategy to improve clinical outcomes and reduce disease burden among heart failure patients in India and similar low- to middle-income settings.

Study Background

Heart failure with reduced ejection fraction (HFrEF) is a leading cause of morbidity and mortality in India, a country facing increasing cardiovascular disease burden due to demographic transition and lifestyle changes. Patients with HFrEF experience recurrent hospitalizations and high mortality rates, imposing substantial healthcare costs and social hardships, especially in rural and low-resource areas. Despite established therapies, gaps remain in optimizing management, particularly regarding adherence to guideline-directed medical therapy and patient self-care. Nurse-coordinated care models supported by digital health tools have emerged internationally as promising interventions for chronic disease management but lacked robust evidence from large pragmatic trials in India. The TIME-HF trial aimed to fill this gap by evaluating whether a comprehensive nurse-led, mobile health-supported collaborative care approach could improve clinical outcomes among Indian patients with HFrEF.

Study Design

The TIME-HF trial was a parallel-group, cluster-randomized controlled trial conducted across 22 centers in India, enrolling 1507 adult patients with established HFrEF. Centers were randomized 1:1 to either the intervention or usual care arm. The intervention incorporated several components:

  • Systematic risk stratification of patients.
  • Optimization of pharmacological treatment according to guidelines.
  • Structured lifestyle counseling and self-care education.
  • Nurse-coordinated follow-up facilitated by mobile health technology enabling active monitoring and communication between healthcare providers and patients.

Participants were followed for a duration of 24 months. The primary outcome was days alive and out of hospital, analyzed via a one-inflated beta regression model. Secondary outcome included all-cause mortality, assessed using Cox proportional hazards models adjusting for cluster randomization.

Key Findings

The trial enrolled 1507 participants (755 intervention; 752 usual care) with a mean age of approximately 62 years. The majority were men (77.6%), many had low educational attainment (70%), and more than half (57.3%) lived in rural areas. Ischemic heart disease was the leading cause of heart failure (77.4%). Baseline characteristics were balanced between groups.

Over 24 months, adherence to follow-up was excellent, with all but one participant completing the full duration. Analysis revealed:

– The probability of survival without hospitalization for the full 730 days was higher in the intervention group (84.0%) than usual care (79.4%), indicating improved patient stability.
– The odds of having 100% days alive and out of hospital were 78% higher in the intervention arm (OR 1.78; 95% CI, 1.42-2.23), demonstrating meaningful clinical benefit beyond standard care.
– Mortality was significantly reduced: 21.59% of intervention patients died by 2 years compared to 26.73% in usual care, yielding a risk ratio of 0.80 (95% CI, 0.67-0.97).
– Cox regression confirmed a 22% relative risk reduction in death with intervention (HR 0.78; P=0.028) after adjusting for cluster effects.

These findings translate to a 4.5 percentage point absolute increase in the probability of remaining out of hospital alive over 2 years.

Expert Commentary

The TIME-HF trial provides compelling evidence supporting nurse-coordinated, digital-assisted collaborative care as a pragmatic and scalable strategy to improve outcomes in HFrEF patients in India. Previous trials globally have demonstrated benefits with multidisciplinary heart failure clinics and digital remote monitoring, but this study is notable for its scale, cluster randomized design, and context within a predominantly low-resource setting with rural representation.

The intervention’s success likely stems from multiple synergistic factors: trained nurses bridging care gaps, mobile health facilitating regular contact and early detection of decompensation, and individualized self-care education fostering adherence. This integrated model addresses common barriers to heart failure management, such as medication non-adherence, knowledge deficits, and inadequate follow-up.

Limitations include the predominantly male study population, potential variability in usual care quality, and lack of blinding inherent to cluster designs. Additionally, although statistical adjustments accounted for clustering, residual confounding cannot be fully excluded. Further research could explore cost-effectiveness, patient-reported outcomes, and applicability to other heart failure phenotypes.

Conclusion

The TIME-HF cluster RCT conclusively demonstrates that a nurse-coordinated, mobile health-supported collaborative care model significantly improves survival and reduces hospitalizations in patients with HFrEF in India. Integration of such models into routine practice could transform heart failure management in India, especially in rural and underserved regions, contributing to better patient outcomes and reduced healthcare system burden. Policymakers and healthcare providers should consider scaling and adapting this approach while continuing to evaluate long-term impacts and resource implications.

Funding and Trial Registration

The study was registered with the Clinical Trials Registry – India (CTRI/2021/11/037797). Funding sources were not specified in the abstract.

References

Jeemon P, Ganapathi S, Anikkady N, et al. Effectiveness of Nurse-Coordinated, Digital-Supported Collaborative Care Model in Reducing Hospital Stay and Mortality Among Patients With Heart Failure: TIME-HF Cluster RCT India. Circulation. Published August 30, 2026. PMID: 42668439. https://pubmed.ncbi.nlm.nih.gov/42668439/

McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44(4):810-819.

Klompstra L, Jaarsma T, Strömberg A. Physical Activity and Exercise Self-Care in Patients With Heart Failure: A Review of the Literature. J Cardiovasc Nurs. 2018;33(3):E1-E12.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Enhancing Survivorship: Multidisciplinary Rehabilitation Improves Cardiorespiratory Fitness in Upper Gastrointestinal Cancer Surgery PatientsRESTORE II RCT demonstrates that a 12-week multidisciplinary rehabilitation program significantly improves cardiorespiratory fitness in survivors of upper gastrointestinal cancer surgery, supporting its integration in post-oncologic care.Sep 17, 2026Bridging Evidence-Based and Personalized Medicine in Heart Failure and Cardiomyopathies: Balancing Standardization with IndividualizationThis article explores the integration of evidence-based medicine and personalized approaches in managing heart failure and inherited cardiomyopathies, proposing a framework to optimize patient care by harmonizing standardized guidelines witSep 17, 2026Impact of an AI-Powered Gamified Mobile Health Application on Blood Pressure Control in a Matched Patient CohortStudy found that use of an AI-driven gamified mobile app integrating home blood pressure monitoring significantly improved blood pressure control compared to usual care in hypertensive patients.Sep 17, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Cardiac Resynchronization Therapy: Metabolomic Insights into Heart Failure Improvement
This study reveals how cardiac resynchronization therapy (CRT) improves left ventricular function in heart failure patients and modulates systemic metabolomic profiles, highlighting differences between ischemic and nonischemic cardiomyopath
Sep 15, 2026
Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant PhenotypesThe PORTHOS study reveals a 16.5% prevalence of heart failure among Portuguese adults aged 50+, with HFpEF constituting over 90% of cases, mostly undiagnosed, highlighting the need for enhanced screening strategies in aging populations.Sep 15, 2026
Genetic Insights into Early Heart Failure Risk in Hypoplastic Left Heart Syndrome: Findings from the NC-DEFINE StudyA prospective study reveals that ultra-rare cardiomyopathy gene variants significantly increase risk for early heart failure in infants with hypoplastic left heart syndrome, highlighting potential for genetic risk stratification and precisiSep 12, 2026